A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/20 (2006.01) A61K 9/22 (2006.01) A61K 9/28 (2006.01)
Patent
CA 2537413
A sustained release solid oral dosage from for treatment of a psychotic disorder, for example schizophrenia, in a mammal is provided, which oral dosage from comprises ziprasidone in an amount effective in treating said psychotic disorder and a pharmaceutically acceptable carrier.
L'invention concerne une forme posologique orale, solide, à libération prolongée destinée au traitement d'un trouble psychotique, par exemple la schizophrénie, chez un mammifère, ladite forme posologique orale comprenant de la ziprasidone en une quantité efficace pour traiter ledit trouble psychotique, ainsi qu'un support pharmaceutiquement acceptable.
Ahmed Imran
Appel Leah Elizabeth
Babcock Walter Christian
Friesen Dwayne Thomas
Herbig Scott Max
Ahmed Imran
Appel Leah Elizabeth
Babcock Walter Christian
Friesen Dwayne Thomas
Herbig Scott Max
LandOfFree
Sustained release dosage forms of ziprasidone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained release dosage forms of ziprasidone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release dosage forms of ziprasidone will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1674384